Showing results (61-70 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|March 27, 2025
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapyDan Atar, Christophe Vandenbriele, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patientsLluís Masana, Eudald Correig, Cèlia Rodríguez-Borjabad, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 19, 2021
Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trialsMattia Galli, Davide Capodanno, Stefano Benenati, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 26, 2022
The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromesAlp Aytekin, J J Coughlan, Gjin Ndrepepa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 3, 2022
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbentRitu Tripathi, Jesus Morales, Victoria Lee, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 12, 2021
Concerns about the use of digoxin in acute coronary syndromesRaffaele Bugiardini, Edina Cenko, Jinsung Yoon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 10, 2022
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trialsRenzo Laborante, Emiliano Bianchini, Attilio Restivo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 19, 2021
Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial‡Ronny Alcalai, Adi Butnaru, Gil Moravsky, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2022
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA RegistryKeith A A Fox, Victor Aboyans, E Sebastian Debus, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
Pageof 53